Vaccines
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.5 | Q2 | 57.6% | 0.955 | Q1 | 82.7% |
| 2024 | 3.4 | Q2 | 62.1% | 1.024 | Q1 | 84.9% |
| 2023 | 5.2 | Q1 | 79.5% | 1.201 | Q1 | 89.3% |
| 2022 | 7.8 | Q1 | 86.5% | 1.655 | Q1 | 94.1% |
| 2021 | 5.0 | Q2 | 70.9% | 1.004 | Q1 | 86.5% |
| 2020 | — | — | 1.296 | Q1 | 90.2% | |
| 2019 | — | — | 1.743 | Q1 | 94.3% | |
| 2018 | — | — | 2.136 | Q1 | 95.6% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2076-393X
country
coverage
2013-2026
